Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pleural Effusion, Malignant 1Early Release of Chromogranin A (CgA) 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Bevacizumab 7Talc 4Pleurodesis 4Thoracoscopy 3Povidone-Iodine 3Paclitaxel 3Drug Therapy 3Doxycycline 3Docetaxel 3Cisplatin 3Chest Tubes 3Carboplatin 3aldesleukin 2Thoracentesis 2Taxes 2Surveys and Questionnaires 2Sodium Chloride 2Silver Nitrate 2Pharmaceutical Preparations 2Nivolumab 2Magnetic Resonance Spectroscopy 2Interleukin-2 2High-Energy Shock Waves 2Gemcitabine 2Fentanyl 2tocilizumab 1talimogene laherparepvec 1romidepsin 1lipoplatin 1cediranib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pleural Effusion, Malignant × Genes, fms × Clear all
NCT04806412 2022-05-17

Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study.

Naestved Hospital

Phase NA Unknown
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡